Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Prostatic Neoplasms 4Breast Neoplasms 3Pancreatic Neoplasms 2Glioblastoma 2Smoking Cessation 1Quality of Life 1Patient Compliance 1Overweight 1Obesity 1Motor Activity 1Melanoma 1Lung Neoplasms 1Inflammation 1Glioma 1GastroEsophageal Cancer 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Advanced Malignant Solid Neoplasm 1

Interventions

Temozolomide 40Magnetic Resonance Spectroscopy 19Radiotherapy 18Specimen Handling 14Radiation 12Bevacizumab 11Lomustine 9pembrolizumab 6fludarabine 5Surgical Procedures, Operative 5atezolizumab 4Nivolumab 4Ipilimumab 4Cyclophosphamide 4Carboplatin 4Biopsy 4cemiplimab 3azeliragon 3Immunoglobulin G 3Disulfides 3Aminolevulinic Acid 3veliparib 2trametinib 2rocakinogene sifuplasmid 2poly ICLC 2olaparib 2lutetium Lu 177 dotatate 2durvalumab 2dabrafenib 2contrast agent BR1 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioblastoma × Diet Therapy × 90 days × Clear all
NCT07091864 2026-05-07

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Mayo Clinic

Phase NA Recruiting
116 enrolled
CNS

Glioblastoma

NCT02286167 2026-03-24

GLAD

Wake Forest University Health Sciences

Phase NA Completed
25 enrolled
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡